Ms Sabrina Chan, Senior Executive Director of HKAPI, was invited to be one of the speakers at a recent webinar about pharmacogenetics on 11 March.
Over 30 members attended the seminar on-site, and 50 joined virtually.
The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.
The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.
The DH met virtually with pharmaceutical associations to discuss a series of measures to maintain the steady supply of medicines.